Studies in pharmaceutical economics
著者
書誌事項
Studies in pharmaceutical economics
(Pharmaceutical sciences)
Pharmaceutical Products Press : Haworth Press, c1996
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Readers of Studies in Pharmaceutical Economics learn the value of economic research in forming health policy while they develop an understanding of the various factors that influence the cost of pharmaceutical care for patients, pharmacists, physicians, and manufacturers. Pharmaceutical economists, product managers, and policymakers learn different methods for controlling costs, patient compliance, therapeutic outcomes, and the effects of restrictions on prescription drugs on the use and cost of other health care services. Above all, readers will find this book provides them with the necessary `know-how'for survival in the dynamic and competitive health care marketplace.The chapters of Studies in Pharmaceutical Economics range in scope from editorials to technical papers on new research methods. Readers will find the following key topics covered:
pricing strategies
marketing implications
policy issues
methods for controlling utilization and cost
multi-tier pricing and its effects on pharmacists and consumers
analytical approaches to researchThis valuable guidebook to the conditions characterizing the growing field of pharmacoeconomics maps the effects of clinical pharmacy services on the lengths of hospital stays, on hospital admissions, on adverse reactions, and on physician's methods and habits of prescription. It also provides readers with practical policy applications and means for assessing trends in the market. These include the effects of extending Medicare coverage to outpatient prescription drugs and a technique for incorporating severity-of-illness measures into analysis of the cost-effectiveness of treatment. Professors of pharmacy administration and their students, product managers and pharmaceutical economists in the drug industry, and drug program administrators can use Studies in Pharmaceutical Economics as an introduction to the ways in which pharmaceutical economic research can bring efficiency and cost-effectiveness into their programs.Professors of pharmacy administration and their students, product managers and pharmaceutical economists in the drug industry, and drug program administrators (medical, HMOs, in service companies) can use Studies in Pharmaceutical Economics as an introduction to the ways in which pharmaceutical economic research can bring efficiency and cost-effectiveness into their programs.
目次
ContentsThe HEW Task Force on Prescription Drugs: An Insider?s Perspective
Health Policy Initiatives and the Utility of Economic Research
The Technology Trust Fund: Paying for Medical Technology
Medicaid Drug Cost Containment: An Economic Perspective
Public Policy and Drug Costs: Legitimate and Bastard Options
The Iowa Pharmacy Capitation Experiment: Economic Incentives and Provider Performance
Incorporating Severity-of-Illness Measures Into Retrospective Claims-Based Cost-Effective Analyses
Initial Impact of a Medicaid Prior Authorization Program for NSAID Prescriptions
Effect of a Medication Utilization Review on Medicaid Health Care Expenditures: A Case Study of Patients with Noninsulin-Dependent Diabetes Mellitus
Impact of an Open Formulary System on the Utilization of Medical Services
A Research Framework for Economic Epidemiology
Socioeconomic Evaluation and the Health Care Industry
Assessment of a Contingent Valuation Technique with Utility Estimation Models
Using Repeated Measures Designs to Evaluate Interventions: A Multivariate Approach
Pharmacoeconomic Analysis of Oral Treatments for Onychomycosis: A Canadian Study
QALYs in Health Outcomes Research: Representation of Real Preferences or Another Numerical Abstraction?
Price Control Policies in the Pharmaceutical Industry: A Selection of Case Studies
Why Medicaid Pays More: A Comparison of Private Payment and Medicaid Prescription Prices, Quantities, Product Mix, and Dosage Forms
Physicians? Perceptions of Prescription Drug Prices: Their Accuracy and Effect on the Prescribing Decision
Does Drug Insurance Influence Physician Prescribing?
An Exploratory Study of Physician Perceptions of Drug Price Information and a Prescription Price Newsletter
Toward an Understanding of Pharmaceutical Pricing Strategies Through the Use of Single Game Theoretic Models
Pricing and Perspectives
Content Analysis of Pharmacoeconomic Appeals in Pharmaceutical Drug Product Advertisements
Economics of Prescription Drug Advertising
The Role of Health Economics in Marketing New Pharmaceuticals Worldwide
The Benefits of Pharmaceutical Promotion: An Economic and Health Perspective
The Financial Implications of Initial Noncompliance: An Investigation of Unclaimed Prescriptions in Community Pharmacies
Noncompliance with Medication Regimens and Subsequent Hospitalizations: A Literature Analysis and Cost of Hospitalization Estimate
Managed Care and Its Effects on Pharmacy Services
Analysis of the Impact of Third-Party Prescription Programs on Community Pharmacy
Third-Party-Associated Cost-Shift Pricing in Georgia Pharmacies
Pharmacy Participation in Third-Party Contracts: Decision Making Through Economic and Financial Analysis
Index
「Nielsen BookData」 より